| Date | Title | Description |
| 21.03.2025 | The Biotech Boom and the Opioid Reckoning: A Tale of Two Industries | In the heart of Europe, a new wave of biotech innovation is rising. Sofinnova Partners has closed a €165 million fund, the Sofinnova Biovelocita II. This fund is a beacon for startups, illuminating the path for groundbreaking therapies. It’... |
| 19.03.2025 | Sofinnova Partners: €165M Biotech Acceleration Fund Closed | Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London, and Milan, announced the final close of Sofinnova Biovelocita II. This fund has exceeded its target, successfully raising €165 million, with s... |
| 19.03.2025 | BioClec Launches With Investment From Sofinnova Partners | BioClec, a Milan, Italy-based biotechnology company focused on breakthrough therapies for Alzheimer’s disease (AD), received an investment from Sofinnova Partners.
The amount of the deal was not disclosed.
The company intends to use the fun... |